Nonparametric Regression Discontinuity Designs with Survival Outcomes}

Maximilian Schuessler Speaker
Stanford University School of Medicine
 
Erik Sverdrup Co-Author
Department of Econometrics & Business Statistics, Monash University
 
Robert Tibshirani Co-Author
Stanford University
 
Stefan Wager Co-Author
Stanford University
 
Sunday, Aug 2: 4:50 PM - 5:05 PM
3241 
Contributed Papers 
Thomas M. Menino Convention & Exhibition Center 
Quasi-experimental evaluations are critical for generating real-world causal evidence and complementing insights from randomized trials. The regression discontinuity design (RDD) is a quasi-experimental framework for estimating causal effects when treatment assignment depends on a running variable crossing a threshold. Such threshold-based rules are ubiquitous in healthcare, where predictive and prognostic biomarkers frequently guide treatment decisions. However, standard RDD estimators rely on complete outcome data, an assumption often violated in time-to-event analyses where censoring arises from loss to follow-up. To address this issue, we propose a nonparametric approach that leverages doubly robust censoring corrections and can be paired with existing RDD estimators. Our approach can handle multiple survival endpoints, long follow-up times, and covariate-dependent variation in survival and censoring. We discuss the relevance of our approach across multiple biomedical applications and demonstrate its usefulness through simulations and the PLCO prostate Cancer Screening Trial. We have also developed an open-source software package rdsurvival for the R language.

Keywords

Causal inference

Regression discontinuity designs

Survival analysis

Statistical learning



Machine learning 

Main Sponsor

Biopharmaceutical Section